##gff-version 3
Q9BZG8	UniProtKB	Chain	1	438	.	.	.	ID=PRO_0000307882;Note=2-(3-amino-3-carboxypropyl)histidine synthase subunit 1	
Q9BZG8	UniProtKB	Region	7	29	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q9BZG8	UniProtKB	Region	391	421	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q9BZG8	UniProtKB	Binding site	110	110	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O58832	
Q9BZG8	UniProtKB	Binding site	214	214	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O58832	
Q9BZG8	UniProtKB	Binding site	342	342	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O58832	
Q9BZG8	UniProtKB	Alternative sequence	1	75	.	.	.	ID=VSP_061760;Note=In isoform 2. Missing	
Q9BZG8	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_061761;Note=In isoform 1 and isoform 5. M->MRRQVM	
Q9BZG8	UniProtKB	Alternative sequence	93	210	.	.	.	ID=VSP_061762;Note=In isoform 5. RFTEAEVMVMGDVTYGACCVDDFTARALGADFLVHYGHSCLIPMDTSAQDFRVLYVFVDIRIDTTHLLDSLRLTFPPATALALVSTIQFVSTLQAAAQELKAEYRVSVPQCKPLSPGE->SSHGHLGPRLPGAVRLCGHPDRHYTPPGLSPPHLSPSHCPCPGQHHSVCVDLAGSRPGAESRVSCECPTVQAPVPWRDPGLHIPPTVQRGGGRCVSWRWPLPSGVCHDCQPQCPRLPV	
Q9BZG8	UniProtKB	Alternative sequence	211	438	.	.	.	ID=VSP_061763;Note=In isoform 5. Missing	
Q9BZG8	UniProtKB	Natural variant	2	2	.	.	.	ID=VAR_036702;Note=In breast and ovarian cancer. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10519411;Dbxref=dbSNP:rs778705666,PMID:10519411	
Q9BZG8	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_036703;Note=In breast and ovarian cancer. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10519411;Dbxref=PMID:10519411	
Q9BZG8	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_059255;Note=I->M;Dbxref=dbSNP:rs8070453	
Q9BZG8	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_086296;Note=In DEDSSH1%3B impairs diphthamide modification of elongation factor 2. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30877278;Dbxref=dbSNP:rs772969956,PMID:30877278	
Q9BZG8	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_086297;Note=In DEDSSH1%3B impairs diphthamide modification of elongation factor 2. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30877278;Dbxref=dbSNP:rs200530055,PMID:30877278	
Q9BZG8	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_086298;Note=In DEDSSH1%3B impairs diphthamide modification of elongation factor 2. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:29362492,ECO:0000269|PubMed:30877278;Dbxref=PMID:29362492,PMID:30877278	
Q9BZG8	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_055706;Note=K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8616839;Dbxref=dbSNP:rs1131600,PMID:8616839	
Q9BZG8	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_076413;Note=In DEDSSH1%3B impairs diphthamide modification of elongation factor 2.. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25558065;Dbxref=dbSNP:rs730882250,PMID:25558065	
Q9BZG8	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_036704;Note=In breast and ovarian cancer%3B requires 2 nucleotide substitutions. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10519411;Dbxref=dbSNP:rs35394823,PMID:10519411	
Q9BZG8	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_036705;Note=In breast and ovarian cancer. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10519411;Dbxref=PMID:10519411	
Q9BZG8	UniProtKB	Sequence conflict	3	3	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9BZG8	UniProtKB	Sequence conflict	157	157	.	.	.	Note=T->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9BZG8	UniProtKB	Sequence conflict	353	353	.	.	.	Note=F->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9BZG8	UniProtKB	Natural variant	6	6	.	.	.	ID=VAR_087452;Note=In DEDSSH1%3B normal diphthamide modification of elongation factor 2. M->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26220823,ECO:0000269|PubMed:30877278;Dbxref=dbSNP:rs757167361,PMID:26220823,PMID:30877278